A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based.<
Pharma is recognising that engaging with highly motivated patients and/or patient organisations can both reduce costs and improve success in clinical trials.
Real-world evidence (RWE) must become a fundamental accompaniment to traditional RCT data in proving value, but uptake has been relatively slow and steady to date
Problems at a contract manufacturing organisation have scuppered Eli Lilly’s hopes of a timely FDA approval for lebrikizumab, its IL-13 inhibitor for the treatment of atop
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho